Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation

https://doi.org/10.1016/0192-0561(93)90060-CGet rights and content

Abstract

Our preceding results have shown that melatonin administration to normal and immunodepressed mice increases significantly the antibody response. We also found that melatonin is able to restore the impaired T-helper cell activity in immunodepressed mice. The present study shows that melatonin enhances antigen presentation by splenic macrophages to T-cells. This effect is concomitant with an increase in the expression of MHC class II molecules and production of IL-1 and TNF-α. Considering the role of antigen presentation and cytokine production in the initiation of the immune response, the present findings provide evidence for relevant mechanisms that may account for the regulatory role of the pineal gland in immunoregulation.

References (32)

  • G.E. Gifford et al.

    Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide

    JNCI

    (1987)
  • J.G. Giri et al.

    Interleukin 1-mediated induction of kappa-light chain synthesis and surface immunoglobulin expression on pre-B cells

    J. Immun.

    (1984)
  • C.M. Hawrylowicz et al.

    Regulation of antigen presentation. II. Anti-Ig and IL-1 induces IL-1 production by murine splenic B cells

    J. Immun.

    (1989)
  • M.K. Hoffman et al.

    An essential role for interleukin 1 and a dual function for interleukin 2 in the immune response of murine B lymphocytes to sheep erythrocytes

    J. Molec. Cell. Immun.

    (1987)
  • A. Kelso et al.

    Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities

    J. Immun.

    (1982)
  • E.A. Kurt-Jones et al.

    Identification of a membrane-associated interleukin 1 in macrophages

  • Cited by (177)

    • Modulation of the immune system by melatonin; implications for cancer therapy

      2022, International Immunopharmacology
      Citation Excerpt :

      However, a reduction of lymphocyte numbers following chemo/radiation therapy may reduce this immunogenic effect of cancer therapy. melatonin alone also has been shown to enhance antigen presentation and activation and maturation of CD8+ T lymphocytes [77]. A combination of melatonin and chemo/radiation therapy may enhance anti-tumour immunity via protection of lymphocytes against apoptosis and also a synergic enhancement of antigen presentation and maturation of DCs [68].

    • Effects of melatonin receptor expression on prognosis and survival in oral squamous cell carcinoma patients

      2022, International Journal of Oral and Maxillofacial Surgery
      Citation Excerpt :

      Moreover, molecular cloning studies of the human G protein-coupled receptor family have identified two distinct classes of high-affinity (20–200 pM) plasma membrane-localized melatonin receptors, referred to as MTNR1A and MTNR1B28–31. Melatonin receptors are expressed on the surface of T lymphocytes and monocytes and increase immunity by activating cytokine production, while also suppressing tumour angiogenesis, cancer cell proliferation, and metastasis15,19,32–35. The binding of melatonin receptors to ligands reduces the intracellular cyclic adenosine monophosphate levels by suppressing adenylate cyclase activity, thereby regulating the activities of protein kinase C, protein kinase A, and mitogen-activated protein kinases17,36–38.

    View all citing articles on Scopus
    View full text